Skip to main content
SpringerLink
Log in

Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Danforth C.H., Trotter M. The distribution of body hair in white subjects. Am. J. Phys. Anthrop 5: 259, 1922.

    Google Scholar 

  2. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women J. Clin. Endocrinol. Metab. 21: 1440, 1961.

    CAS  Google Scholar 

  3. McKnight E. The prevalence of hirsutism in young women. Lancet i: 400, 1964.

    Google Scholar 

  4. Lorenzo E.M. Familial study of hirsutism. J. Clin. Endocrinol. Metab. 31: 556, 1970.

    Google Scholar 

  5. Madanes A.E., Novotny M. The vellus index: a new method of assessing hair growth. Fertil. Steril. 48: 1064, 1987.

    PubMed  CAS  Google Scholar 

  6. Casey J.H., Burger H.G., Kent J.R., Kellie A.E. Treatment of hirsutism by adrenal and ovarian suppression. J. Clin. Endocrinol. Metab. 26: 1370, 1966.

    PubMed  CAS  Google Scholar 

  7. Cumming D.C., Yang J.C., Rebar R.W., Yen S.S.C. Treatment of hirsutism with spironolactone. JAMA 247: 1295, 1982.

    PubMed  CAS  Google Scholar 

  8. Rosenfield R.L. Pilosebaceous physiology in relation to hirsutism and acne. Clin. Endocrinol. Metab 15:2, 341, 1986.

    PubMed  CAS  Google Scholar 

  9. Kligman A.M. The human hair cycle. J. Invest. Dermatol. 33: 307, 1959.

    PubMed  CAS  Google Scholar 

  10. Myers R.J., Hamilton J.B. Regeneration and rate of growth of hairs in man. Ann. N. Y. Acad. Sci. 53: 562, 1951.

    PubMed  CAS  Google Scholar 

  11. Pelfini C., Cerimele D., Pisanu G. Aging of the skin and hair growth in man. Advances in the Biology of the skin 9: 153, 1969.

    Google Scholar 

  12. Ebling F.J.G., Randall V.A., Sawers R.S. Interrelationships between body hair growth, sebum excretion and endocrine parameters. Prostate 5: 347, 1984.

    Google Scholar 

  13. Ebling F.J.G. Hair follicles and associated glands as androgen targets. Clin. Endocrinol. Metab. 15:2, 319, 1986.

    PubMed  CAS  Google Scholar 

  14. Leshin M., Wilson J. Mechanisms of androgen-mediated hair growth. In: Orfanos C.E., Montagna W., Stuttgen G. (Eds.), Hair research. Springer-Verlag, Berlin. 1981, p.. 205–209.

    Google Scholar 

  15. Hamilton J.B. Effect of castration in adolescent and young adult males upon further changes in the proportions of bare and hairy scalp. J. Clin. Endocrinol. Metab. 20: 1309, 1960.

    PubMed  CAS  Google Scholar 

  16. Kollar E.J. The induction of follicles by embryonic dermal papillae. J. Invest. Dermatol. 55: 374, 1970.

    PubMed  CAS  Google Scholar 

  17. Cunha G.R., Chung L.W.K., Shannon J.M., Taguchi O., Fuji H. Hormone-induced morphogenesis and growth: role of mesenchymal- epithelial interactions. Recent Prog. Horm. Res. 39: 559, 1983.

    PubMed  CAS  Google Scholar 

  18. Maudelonde T.M., Rosenfield R.L., Schuler C.F., Schwartz S.A. Studies of androgen metabolism and action in cultured hair and skin cells. J. Steroid Biochem. 5: 1053, 1986.

    Google Scholar 

  19. Moore R.J., Gazak J.M., Wilson J.D. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17ß estradiol. Ann. N.Y. Acad. Sci. 83: 463, 1979.

    Google Scholar 

  20. Rosenfield R.L., Furlanetto R. Physiologic induction of puberty increases somatomedin-C. J. Pediatr. 107: 415, 1985.

    PubMed  CAS  Google Scholar 

  21. Zachmann M., Prader A. Anabolic and androgenic effect of testosterone in sexually immature boys and its dependency on growth hormone. J. Clin. Endocrimol. Metab. 30: 85, 1970.

    CAS  Google Scholar 

  22. Rothe M., Falanga V. Growth factors. Their biology and promise in dermatologic diseases and tissue repair. Arch. Dermatol. 125: 1390, 1989.

    CAS  Google Scholar 

  23. Pans R., Link R.E. The psoriatic epidermal lesion and anagen hair growth may share the same “switch on” mechanism Yale Biol. Med. 61: 467, 1988.

    Google Scholar 

  24. Lubrano C., Petrangeli E., Catizone A., Santonati A., Concolino G., Rombolà N., Frati L., Di Silverio F., Sciarra F. Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia. J. Steroid Biochem. 34: 499, 1989.

    PubMed  CAS  Google Scholar 

  25. Tammi R., Santti R. Morphometric analysis of human epidermis treated with testosterone and dehydroepiandrosterone in organ culture. Arch. Dermatol. Res. 281: 417, 1989.

    PubMed  CAS  Google Scholar 

  26. Agache P., Blanc D., Barrand C., Laurent R. Sebum levels during the first year of life. J. Invest. Dermatol. 42: 421, 1980.

    Google Scholar 

  27. Rosenfiel R.L., Rich B.H., Lucky A.W. Adrenarche as cause of benign pseudopuberty in boys. J. Pediatr. 101: 1005, 1982.

    Google Scholar 

  28. Plewing G., Kligman A.M. Proliferative activity of the sebaceous glands of the aged. J. Invest. Dermatol. 70: 314, 1978.

    Google Scholar 

  29. Pochi P.E., Strauss J.S., Mescon H. Sebum secretion and urinary fractional 17-ketosteroid and total 17-hydroxycorticosteroid excretion in male castrates. J. Invest. Dermatol. 39: 475, 1962.

    PubMed  CAS  Google Scholar 

  30. Pochi P.E., Strauss J.S., Downing D.T. Age-related changes in sebaceous gland activity. J. Invest. Dermatol. 73: 108, 1979.

    PubMed  CAS  Google Scholar 

  31. Brind J.L., Marinescu D., Gomez E.C., Wheatley V.R., Orentreich N. In vitro testosterone metabolism in the mouse preputial gland: intercellular co-operation and changes with cell maturation. J. Endocrinol. 100: 377, 1984.

    PubMed  CAS  Google Scholar 

  32. Voigt W., Sawaya M.E., Hsia S.L. Mechanism of action of dehydroepiandrosterone in the sebaceous gland. Proc. Int. Symp. on “The Regulation of Androgen Action” Montreal, Quebec, Abstract 213, June 1984.

  33. Adachi K., Kano M. The role of receptor proteins in controlling androgen action on the sebaceous glands of hamsters. Steroids 19: 567, 1972.

    PubMed  CAS  Google Scholar 

  34. Shuster S., Thody A.J. The control and measurement of sebum secretion. J. Invest. Dermatol. 62: 172, 1974.

    PubMed  CAS  Google Scholar 

  35. Thody A.J., Shuster S. Control of sebum secretion by posterior pituitary. Nature 237: 346, 1972.

    PubMed  CAS  Google Scholar 

  36. Thody A.J., Shuster S. A study of the relationship between the thyroid gland and sebum secretion in the rat. J. Endocrinol. 54: 239, 1972.

    PubMed  CAS  Google Scholar 

  37. Verschoore M. Aspects hormonaux de l’acné. Ann. Dermatol. Venereol. 114: 439, 1987.

    PubMed  CAS  Google Scholar 

  38. Dorfman R.I., Shipley R.A. Androgens: Biochemestry, Physiology and Clinical Significance. John Wiley, New York, 1956, p. 590.

    Google Scholar 

  39. Hechter O., Solomon M.M., Zaffaroni A., Pincus G. Transformation of cholesterol and acetate to adrenal cortical hormones. Arch. Biochem. Biophys. 46: 201, 1953.

    PubMed  CAS  Google Scholar 

  40. Brown M.S., Kovanen P.T., Goldstein J.L. Receptor-mediated uptake of lipoprotein-cholesterol and its utilization for steroid synthesis in the adrenal cortex. Recent. Prog. Horm. Res. 35: 215, 1979.

    PubMed  CAS  Google Scholar 

  41. Miller W.L. Molecular biology of steroid hormone synthesis. Endocr. Rev. 9: 295, 1988.

    PubMed  CAS  Google Scholar 

  42. Grumbach M.M., Richards J.E., Conte F.A., Kaplan S.L. Clinical disorders of adrenal function and puberty: an assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimulating hormone. In: James V.H.T. (Ed.), The endocrine function of the human adrenal cortex. Academic Press, London, 1978, p. 583.

    Google Scholar 

  43. Parker LN., Odell W.D. Evidence for existence of cortical androgen stimulating hormone: Am. J. Physiol. 236: E616, 1979.

    PubMed  CAS  Google Scholar 

  44. Parker L.N., Lifrak E.T., Odell W.D. A 60,000 molecular weight human pituitary glycopeptide stimulates adrenal androgen secretion. Endocrinology 113: 2092, 1983.

    PubMed  CAS  Google Scholar 

  45. Toscano V., Balducci R., Adamo M.V., Mangiantini A., Cives C., Boscherini B. Changes in steroid pattern following acute and chronic adrenocorticotropin administration in premature adrenarche. J. Steroid Biochem. 32: 321, 1989.

    PubMed  CAS  Google Scholar 

  46. Ghizzoni L., Virdis R., Ziveri M., Lamborghini A., Alberini A., Volta C., Bernasconi S. Adrenal steroid, cortisol, adrenocorticotropin, and endorfin responses to human corticotropin-releasing hormone stimulation test in normal children and in children with premature pubarche. J. Clin. Endocrinol. Metab. 69: 875, 1989.

    PubMed  CAS  Google Scholar 

  47. Kreitzer P.M., Blethen S.L., Festa R.S., Chasalow F.I. Dehydroepiandrosterone sulfate levels are not sup- pressible by glucocorticoids before adrenarche. J. Clin Endocrinol. Metab. 69: 1309, 1989.

    PubMed  CAS  Google Scholar 

  48. Marsh J.M., Savard K., Lamaire W.J. Steroidogenic capacities of the different compartments of the human ovary. In: James V.H.T., Serio M., Giusti G. (Eds.), The endocrine function of the human ovary. Academic Press, London, 1976, p. 37.

    Google Scholar 

  49. Judd H.L., Yen S.S.C. Serum androstenedione and testosterone levels during the menstrual cycle. J. Clin Endocrinol. Metab. 36: 475, 1973.

    PubMed  CAS  Google Scholar 

  50. Longcope C., Hunter R., Franz C. Steroid secretion by the postmenopausal ovary. Am J. Obstet. Gynecol. 138: 564, 1980.

    PubMed  CAS  Google Scholar 

  51. Erickson G.F., Magoffin D.A., Dyer C.A., Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr. Rev. 6: 371, 1985.

    PubMed  CAS  Google Scholar 

  52. Toscano V. Dihydrotestosterone metabolism. Clin. Endocrinol. Metab. 15: 279, 1986.

    PubMed  CAS  Google Scholar 

  53. Horton R., Lobo R. Peripheral androgens and the role of androstenediol glucuronide. Clin. Endocrinol. Metab. 15: 293, 1986.

    PubMed  CAS  Google Scholar 

  54. Toscano V., Horton R. Circulating dihydrotestosterone may not reflect peripheral formation. J. Clin. Invest. 79: 1653, 1987.

    PubMed Central  PubMed  CAS  Google Scholar 

  55. Rittmaster R.S., Thompson D.L., Listwak S., Loriaux D.L. Androstenediol glucuronide isomers in normal men women and in men infused with labeled dihydrotestosterone. J. Clin. Endocrinol. Metab. 66: 212, 1988.

    PubMed  CAS  Google Scholar 

  56. Ross J.B.A., Petra P.H., Gurpide E. Estradiol entry into endometrial cells in suspension J. Steroid Biochem. 23: 145, 1985.

    Google Scholar 

  57. Reilly J., Rfkind I., Longcope C. Effect of serum proteins on estrogen-mediated receptor translocation in the superfused rat uterus. J. Steroid Biochem. 28: 717, 1987.

    PubMed  CAS  Google Scholar 

  58. Petra P.H., Stanczyk F.Z., Namkung P.C., Fritz M.A., Novy M.J. Direct effect of sex steroid-binding globulin (SBP) of plasma on the metabolic clearance rate of testosterone in the Rhesus macaque. J. Steroid Biochem. 22: 739, 1985.

    PubMed  CAS  Google Scholar 

  59. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 11: 80, 1990.

    PubMed  CAS  Google Scholar 

  60. Hryb D.J., Khan M.S., Romas N.A., Rosner W. The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones. J. Biol. Chem. 265: 6048, 1990.

    PubMed  CAS  Google Scholar 

  61. Mauvais-Jarvis P. Androgen metabolism in human skin: mechanisms of control. In: Martini L., Motta M. (Eds.), Androgens and Antiandrogens. Raven Press, New York, 1977, p. 229.

    Google Scholar 

  62. Kutten F., Mowszowicz I., Schaison G., Mauvais-Jarvis P. Androgen production and skin metabolism in hirsutism. J. Endocrinol. 75: 83, 1977.

    Google Scholar 

  63. Mauvais-Jarvis P., Kutten F., Mowszowicz I. Hirsutism, Monograph on Endocrinology Vol. 19. Springer Verlag, Berlin, Heidelberg, New York, 1981, 74.

    Google Scholar 

  64. Mowszowicz I., Melanitou E., Kirchoffer M.O., Mauvais-Jarvis P. Dihydrotestosterone stimulates 5α reductase activity in pubic skin fibroblasts (PFS). J. Clin. Endocrinol. Metab 56: 320, 1983.

    PubMed  CAS  Google Scholar 

  65. Bonne C., Saurat J.H., Chivot M., Lehuchet D., Raynaud J.P. Androgen receptors in human skin. Br. J. Dermatol. 97: 501, 1977.

    PubMed  CAS  Google Scholar 

  66. Mowszowicz I., Riahi M., Wright F., Bouchard P., Kutten F., Mauvais-Jarvis P. Androgen receptor in human skin cytosol. J. Clin. Endocrinol. Metab. 52: 338, 1981.

    PubMed  CAS  Google Scholar 

  67. Mowszowicz I., Melanitou E., Doukani A., Wright F., Kutten F., Mauvais-Jarvis P. Androgen binding capacity and 5αreductase activity in pubic skin fibroblasts from hirsute patients. J. Clin. Endocrinol. Metab. 56: 1209, 1983.

    PubMed  CAS  Google Scholar 

  68. Eil C., Cutler G.B., Loriaux D.L. Androgen receptor characteristics in skin fibroblasts in human foreskin. J. Invest. Dermatol. 84: 62, 1985.

    PubMed  CAS  Google Scholar 

  69. Serafini P., Ablan F., Lobo R.A. 5α reductase activity in the genital skin of hirsute women. J. Clin. Endocrinol. Metab. 60: 349, 1985.

    PubMed  CAS  Google Scholar 

  70. Serafini P., Lobo R.A. Increased 5α reductase activity in idiopathic hirsutism. Fertil. Steril. 43: 74, 1985.

    PubMed  CAS  Google Scholar 

  71. Pasupuleti V., Horton R. Insulin-like growth factor can alter steroid 5α reductase activity and formation of dihydrotestosterone in skin fibroblasts. 72nd Endocrine Society Meeting — Atlanta 1990 (abstract 414).

  72. Rosenfield R.L. Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. J. Clin. Endocrinol. Metab. 32: 717, 1971.

    PubMed  CAS  Google Scholar 

  73. Burke C.W., Anderson D.C. Sex-hormone-binding-globulin is an estrogen amplifier. Nature 240: 38, 1972.

    PubMed  CAS  Google Scholar 

  74. Anderson D.C. Sex-hormone-binding-globulin. Clin. Endocrinol. (Oxf.) 3: 69, 1974.

    CAS  Google Scholar 

  75. Paulsen J.D., Keller D.W., Wiest W.G., Warren J.C. Free testosterone concentration in serum: elevation is the hallmark of hirsutism. Am. J. Obstet. Gynecol. 128: 851, 1977.

    Google Scholar 

  76. Mathur R.S., Moody L.O., Landgrebbe S., Williamson H.O. Plasma androgens and sex-hormone-binding-globulin in the evaluation of hirsute females. Fertil. Steril. 35: 29, 1981.

    PubMed  CAS  Google Scholar 

  77. Pardridge W.M. Serum bioavailability of sex steroid hormones. Clin. Endocrinol. Metab. 15: 259, 1986.

    PubMed  CAS  Google Scholar 

  78. Mendel CM. The free hormone hypothesis:a physiologically based mathematical model. Endocr. Rev. 10: 232, 1989.

    PubMed  CAS  Google Scholar 

  79. Siiteri P.K., Simberg N.H. Changing concepts of active androgens in blood. Clin. Endocrinol. Metab. 15: 247, 1986.

    PubMed  CAS  Google Scholar 

  80. Toscano V., Caiola S., Maroder M., Casilli D., Balducci R., Sciarra F. Lack of correlation between sex hormone binding globulin and free testosterone in some cases of “idiopathic” hirsutism. J. Endocrinol. Invest. 10: 83, 1987.

    PubMed  CAS  Google Scholar 

  81. Nestler J.E., Powers L.J., Matt D. W., Steingold K.A., Plymate S.R., Clore J.N., Blackard W.G. Insulin directly suppresses serum sex hormone-binding globulin levels in obese women with poly-cystic ovary syndrome. 72nd Endocrine Society Meeting — Atlanta 1990 (abstract 713)

  82. Hollander C.S., Scott R.L, Burgess J.A., Rabinowitz D., Merimee T.J., Oppenheimer J.H. Free fatty acid: a possible regulator of free thyroid hormone levels in man. J. Clin. Endocrinol. Metab. 27: 1219, 1967.

    PubMed  CAS  Google Scholar 

  83. Chopra I.J., Huang T.S., Hurd R.E., Beredo A., Solomon D.H. Relationship between serum free fatty acid and thyroid hormone binding inhibitor in non thyroid illnes J. Clin. Endocrinol. Metab. 60: 980, 1985.

    CAS  Google Scholar 

  84. Reed M.J., Beranek P.A., Cheng R.W., James V.H.T. Free fatty acids: a possible regulator of the available estradiol fractions in plasma. J. Steroid Biochem. 24: 657, 1986.

    PubMed  CAS  Google Scholar 

  85. Mooradian A.D., Pamplona D.M., Viosca S.P., Korenman S.G. Effect of free fatty acids on the bioavailability of plasma testosterone and dihydrotestosterone. J. Steroid Biochem. 29: 369, 1988.

    PubMed  CAS  Google Scholar 

  86. Reed M.J., Cheng R.W., Simmonds M., Richmond W., James V.H.T. Dietary lipids: an additional regulator of plasma levels of sex hormone binding globulin. J. Clin. Endocrinol. Metab. 64: 1083, 1987.

    PubMed  CAS  Google Scholar 

  87. Belanger A., Locong A., Noel C., Cusan L., Dupont A., Prevost J., Caron S., Sevigny J. Influence of diet on plasma steroid and sex hormone binding globulin in adult men. J. Steroid Biochem. 32: 829, 1989.

    PubMed  CAS  Google Scholar 

  88. Plymate S.R., Farris B.L., Bassett M.L., Matej L. Obesity and its role in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 52: 1246, 1981.

    PubMed  CAS  Google Scholar 

  89. Kiddy D.S., Sharp P.S., White D.M., Scanion M.F., Mason H.D., Bray C.S., Poison D.W., Reed M.J., Franks S. Differences in clinical and endocrine features between obese and non obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin. Endocrinol. (Oxf.) 32: 213, 1990.

    CAS  Google Scholar 

  90. Kiddy D.S., Hamilton-Fairley D., Seppala M., Koistinen R., James V.H.T., Reed M.J., Franks S. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin like growth factor-I Clin. Endocrinol. 31: 757, 1989.

    CAS  Google Scholar 

  91. Longcope C., Fineberg S.E. Production and metabolism of dihydrotestosterone in peripheral tissues. J. Steroid Biochem. 23: 415, 1985.

    PubMed  CAS  Google Scholar 

  92. Kirschner M.A., Samojlik E., Silber D. A comparison of androgen production and clearance in hirsute and obese women. J. Steroid Biochem. 19: 607, 1983.

    PubMed  CAS  Google Scholar 

  93. Longcope C., Pratt J.H., Schneider S.H., Fineberg S.E. The in vivo metabolism of androgens by muscle and adipose tissue of normal men. Steroids 28: 521, 1976.

    PubMed  CAS  Google Scholar 

  94. Horton R., Hawks D., Lobo R. 3α, 17ß androstanediol glucuronide in plasma. J. Clin. Invest.69: 1203, 1982.

    PubMed Central  PubMed  CAS  Google Scholar 

  95. Deslypere J.P., Sayed A., Punjabi V., Verdonk L., Vermeulen A. Plasma 5α androstane-3α, 17ß diol and urinary 5α androstane-3α, 17ß diol glucuronide parameters of peripheral androgen action: a comparative study. J. Clin. Endocrinol. Metab. 54: 386, 1982.

    PubMed  CAS  Google Scholar 

  96. Toscano V., Sciarra F., Adamo M.V., Petrangeli E., Foli S., Caiola S., Conti C. Is 3α androstanediol a marker of peripheral hirsutism? Acta Endocrinol. 99: 314, 1982.

    PubMed  CAS  Google Scholar 

  97. Horton R. Markers of peripheral androgen production. In: Serio M., Martini L. (Eds.), Sexual differentiation Academic Press, New York, 1984, p. 261.

  98. Kirschner M.A., Samojlik E., Szmal E. Clinical usefulness of plasma androstenediol glucuronide measurements in women with idiopathic hirsutism. J. Clin. Endocrinol. Metab. 65: 597, 1987.

    PubMed  CAS  Google Scholar 

  99. Meikle A.W., Stringham J.D., Wilson D.E., Dolman L.I. Plasma 5α-reduced androgens in men and hirsute women: role of adrenals and gonads. J. Clin. Endocrinol. Metab. 48: 969, 1979.

    PubMed  CAS  Google Scholar 

  100. Mauvais-Jarvis P., Charransol G., Bobas-Masson. Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity. J. Clin. Endocrinol. Metab. 36: 452, 1973.

    PubMed  CAS  Google Scholar 

  101. Ishimaru T., Edmiston A., Pages L., Horton R. Splanchnic extraction and conversion of testosterone and dihydrotestosterone in man. J. Clin. Endocrinol. Metab. 46: 528, 1978.

    PubMed  CAS  Google Scholar 

  102. Morimoto I., Edmiston A., Hawks D., Horton R. Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men J. Clin. Endocrinol. Metab. 52: 772, 1981.

    CAS  Google Scholar 

  103. Sciarra F., Toscano V., Casilli D., Adamo M.V., Maroder M., Conti C. 3α androstanediol concentrations in ovarian and adrenal blood effluents in normal and hirsute women. VII International Congress of Endocrinology. Excerpta Medica, Amsterdam/Oxford/Princeton, Abstract 1345.

  104. Chung L., Coffee D. Androgen glucuronide I. Direct formation in rat accessory sex organs. Steroids 30: 223, 1977.

    PubMed  CAS  Google Scholar 

  105. Lobo R., Shoupe D., Serafini P., Brinton D., Horton R. The effect of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil. Steril. 43: 200, 1985.

    PubMed  CAS  Google Scholar 

  106. Belanger A., Brochu M., Cliche J. Plasma levels of steroid glucuronides in prepubertal, adult and elderly men. J. Steroid Biochem. 24: 1069, 1986.

    PubMed  CAS  Google Scholar 

  107. Greep N., Hoopes M., Horton R. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women. J. Clin. Endocrinol. Metab. 62: 22, 1986.

    PubMed  CAS  Google Scholar 

  108. Gompel A., Wright F., Kutten F., Mauvais-Jarvis P. Contribution of plasma androstenedione to 5α androstanediol glucuronide in women with idiopathic hirsutism. J. Clin. Endocrinol. Metab. 62: 441, 1986.

    PubMed  CAS  Google Scholar 

  109. Brochu M., Belanger A., Tremblay R.R. Plasma levels of C-19 steroids and 5α-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women. Fertil. Steril. 49: 948, 1987.

    Google Scholar 

  110. Scanion M.J., Whorwood C.B., Franks S., Reed M.J., James V.H.T. Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction. Clin. Endocrinol. (Oxf) 29: 529, 1988.

    Google Scholar 

  111. Rittmaster R.S., Thompson D.L. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J. Clin. Endocrinol. Metab. 70: 1096, 1990.

    PubMed  CAS  Google Scholar 

  112. Toscano V., Adamo M.V., Caiola S., Foli S., Petrangeli E., Casilli D., Sciarra F. Is hirsutism an evolving syndrome? J. Endocrinol. 97: 379, 1983.

    PubMed  CAS  Google Scholar 

  113. R. Balducci, Toscano V. Bioactive and peripheral androgens in prepubertal simple hypertrichosis. Clin. Endocrinol (Oxf.) 33: 407, 1990.

    CAS  Google Scholar 

  114. Matteri R.K., Stanczyk F.Z., Kaufman F.R., Delgado C., Gentzchein E., Lobo R.A. Production of C19 Sulfates and glucuronides in human genital skin. 70th Endocrine Society Meeting — New Orleans 1988, (Abstract 747).

  115. Montalto J., Funder J.W., Yong A.B.W., Callan A., Davies H.E., Connelly J.F. Serum C-19 steroid sulphates in females with clinical hyperandrogenism. J. Steroid Biochem. 34: 531, 1989.

    Google Scholar 

  116. Lookingbill D.P., Horton R., Demers L.M., Egan N., Marks J.G., Santen R.J. Tissue production of androgens in women with acne. J. Am. Acad. Dermatol. 12: 481, 1985.

    PubMed  CAS  Google Scholar 

  117. Balducci R., Adamo M.V., Bianchi P., Mangiantini A., Municchi G., Bacchielli B., Toscano V. Sex hormone binding globulin (SHBG), Diidrotestosterone (DHT) e 3α androsanediolo (3Ad) plasmatici in adolescenti affette da acne di origine extraghiandolare e da irsutismo periferico. In: Saggese G. (Eds.), Endocrinologia Pediatrica, Monduzzi, Bologna 1988, p. 31–34.

  118. Toscano V., Adamo M.V., Bianchi P., Mangiantini A., Municchi G., Rombolà N., Balducci R. 3α androstanediol and its glucuronide: different pattern in acne and hirsutism. J. Endocrinol. Invest. 11(suppl. 2): 27, 1988 (Abstract).

    Google Scholar 

  119. Bouchard P., Kutten F., Mowszowicz I., Schaison G., Raux-Eurin M.C., Mauvais-Jarvis P. Congenital adrenal hyperplasia due to partial 21-hydroxylase deficiency. A study of five cases. Acta Endocrinol. (Copenh.) 96: 107, 1981.

    CAS  Google Scholar 

  120. Kohn B., Levine L.S., Pollack M.S., Pang S., Lorenzen F., Levy D., Lerner A.J., Rondanini G.F., Dupont B., New M.I. Late onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia J. Clin. Endocrinol. Metab. 55: 817, 1982.

    PubMed  CAS  Google Scholar 

  121. Balducci R., Bacchielli B., Caiola S., Casilli D., Chini L, Cives C., Lalli A., Maroder M., Toscano V. Differential clinical features of late onset adrenogenital syndrome. Importance of early diagnosis. Minerva Endocrinol. 9: 7, 1984.

    PubMed  CAS  Google Scholar 

  122. White P.C., New M.I., Dupont B. Congenital adrenal hyperplasia (first of two parts). N. Engl. J. Med. 316: 1519, 1987.

    PubMed  CAS  Google Scholar 

  123. White P.C., New M.I., Dupont B. Congenital adrenal hyperplasia (second of two parts). N. Engl. J. Med. 316: 1580, 1987.

    PubMed  CAS  Google Scholar 

  124. Pang S., Lerner A.J., Stoner E., Levine L.S., Oberfield S.E., Engel I., New M.I. Late-onset adrenal steroid 3ß-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women. J. Clin. Endocrinol. Metab. 60: 428, 1985.

    PubMed  CAS  Google Scholar 

  125. Kutten F., Coullin P., Girard F., Billaud L., Vincens M., Boucekkine C., Thalabard J.C., Maudelonde T., Spritzer P., Mowszowicz I., Boue A., Mauvais-Jarvis P. Late-onset adrenal hyperplasia. N. Engl. J. Med. 313: 224, 1985.

    Google Scholar 

  126. Bongiovanni A.M. The response of several adrenocortical steroids to the administration of ACTH in hirsute women. J. Steroid Biochem. 18: 745, 1983.

    PubMed  CAS  Google Scholar 

  127. Temeck J.W., Pang S., Nelson C., New M.I. Genetic defects of steroidogenesis in prematue pubarche. J. Clin. Endocrinol. Metab. 14: 609, 1987.

    Google Scholar 

  128. Laron Z., Pollack M.S., Zamir R., Roitman A., Dickerman Z., Levine L.S., Lorenzen F., O’Neill G.J., Pang S., New M.I., Dupont B. Late onset 21-hydroxylase deficiency and HLA in Ashkenazi population: new allele at the 21-hydroxylase locus. Hum. Immunol. 1: 55, 1980.

    PubMed  CAS  Google Scholar 

  129. Speiser P.W., Dupont B., Rubinstein P., Piazza A., Kastelan A., New M.I. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 37: 650, 1985.

    PubMed Central  PubMed  CAS  Google Scholar 

  130. Speiser P.W., New M.I. Genotype and hormonal phenotype in non classical 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 64: 86, 1987.

    PubMed  CAS  Google Scholar 

  131. Newmark S., Dluhy R.G., Williams G.H., Pochi P., Rose L.I. Partial 11ß- and 21-hydroxylase deficiencies in hirsute women. Am. J. Obstet. Gynecol. 127: 594, 1977.

    Google Scholar 

  132. Cathelineau G., Brerault J.L., Fiet J., Julien R., Dreux C., Canivet J. Adrenocortical 11 ß -hydroxylation defect in adult women with postmenarchial onset of symptoms. J. Clin. Endocrinol. Metab. 51: 287, 1980.

    PubMed  CAS  Google Scholar 

  133. Gutrie J.P. Jr., Wilson E.A., Quillen D.L., Jawad M.J. Adrenal androgen excess and definitive 11 ß-hydroxilation in women with idiopathic hirsutism. Arch. Intern. Med. 142: 729, 1982.

    Google Scholar 

  134. Bongiovanni A.M. Acquired adrenal hyperplasia: with special reference to 3ß-hydroxysteroid dehydrogenase. Fertil. Steril. 35: 599, 1981.

    PubMed  CAS  Google Scholar 

  135. Lobo A.R., Goebelsmann U. Evidence for reduced 3ß-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 53: 394, 1981.

    PubMed  CAS  Google Scholar 

  136. Toscano V., Caiola S., Maroder M., Adamo M.V., Argiolas L, Familiari A., Familiari G. Effects of dihydrotestosterone treatment on adrenal gland function and morphology in adult female guinea pigs. J. Steroid Biochem. 36: 89, 1990.

    PubMed  CAS  Google Scholar 

  137. Reining J.W., Doppman J.L., Dwyer A.J., Johnson A.R., Knop R.H. Adrenal masses differentiated by MR. Radiology 158: 81, 1986.

    Google Scholar 

  138. Vaitukaitis J.L. Polycystic-ovary syndrome-what is it? N. Engl. J. Med. 309: 1245, 1983.

    PubMed  CAS  Google Scholar 

  139. Yen S.S. The polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 12: 177, 1980.

    CAS  Google Scholar 

  140. McKenna T.J. Pathogenesis and treatment of polycystic ovary syndrome. N. Eng. J. Med. 318: 558, 1988.

    CAS  Google Scholar 

  141. Barnes R., Rosenfield R.L. The polycystic ovary syndrome: pathogenesis and treatment. Ann. Intern. Med. 110: 386, 1989.

    PubMed  CAS  Google Scholar 

  142. Rosenfield R.L., Rich B.H., Wolfsdorf J.I., Cassorla F., Parks J.S., Bongiovanni A.M., Wu C.H., Shackleton C.H.L. Pubertal presentation of congenital 3-ß-ol-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 51: 345, 1980.

    PubMed  CAS  Google Scholar 

  143. Axelrod L.R., Goldzieher J.W., Ross S.D. Concurrent 3ß-hydroxysteroid dehydrogenase deficiency in adrenal and sclerocystic ovary. Acta Endocrinol. (Copenh.) 48: 392, 1962.

    Google Scholar 

  144. Pang S., Softness B., Sweeney W.J. 3d, New M.I. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency. N. Engl. J. Med. 316: 1295, 1987.

    PubMed  CAS  Google Scholar 

  145. Toscano V., Balducci R., Bianchi P., Mangiantini A., F. Sciarra. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease. J. Clin. Endocrinol. Metab. 71: 288, 1990.

    PubMed  CAS  Google Scholar 

  146. Maschler I., Salzberger M., Finkelstein M. 11ß-hydroxylase with affinity to C-21-deoxysteroids from ovaries of patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 41: 999, 1975.

    PubMed  CAS  Google Scholar 

  147. Finkelstein M, Weidenfeld J. Perceptions on the etiology of the polycystic ovary syndrome. In: Fotherby K. and Pal S.B. (Eds), Hormones in normal and abnormal tissues. W. De Gruyter & Co., Berlin, New York, 1983.

    Google Scholar 

  148. Barnes R.B., Rosenfield R.L., Burstein S., Ehrmann DA Pituitary-ovarian response to naferelin testing in polycystic ovary syndrome. N. Engl. J. Med. 320: 559, 1989.

    PubMed  CAS  Google Scholar 

  149. Adashi E.Y., Resnicj C.E., D’Ercole A.J., Svoboda M.E., Van Wyk J.J. Insulin-like growth factors as intra-ovarian regulators of granulosa cells growth and function. Endocr. Rev. 6: 400, 1985.

    PubMed  CAS  Google Scholar 

  150. Barbieri R.L., Makris A., Randal R.W., Daniels G., Kistner R.W., Ryan K.J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 62: 904, 1986.

    PubMed  CAS  Google Scholar 

  151. Burghen G.A., Givens J.R., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50: 113, 1980.

    PubMed  CAS  Google Scholar 

  152. Pasquali R., Casimirri F., Venturoli S., Paradisi R., Mattioli L., Capelli M., Meichionda M., Labo G. Insulin resistence in patients with polycystic ovaries: its relationship to body weight and androgen levels. Acta Endocrinol. (Copenh.) 104: 110, 1983.

    CAS  Google Scholar 

  153. Chang R.J., Nakamura R.M., Judd H.L, Kaplan S.A. Insulin resistance in non obese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 57: 356, 1983.

    PubMed  CAS  Google Scholar 

  154. Dunaif A., Graf M., Mandeli J., Lumas V., Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia. J. Clin. Endocrinol. Metab. 65: 499, 1987.

    PubMed  CAS  Google Scholar 

  155. Hillier S.G., Ross G.T. Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biol. Reprod. 20: 261, 1979.

    PubMed  CAS  Google Scholar 

  156. Rosenfield R.L. Congenital adrenal hyperplasia and reproductive function in females. In: Flamigni C., Venturoli S., Givens J. (Eds.), Adolescence in females. Year Book Medical Publisher Inc., Chicago, 1985, p. 373.

    Google Scholar 

  157. Chrousos G.P., Loriaux D.L., Mann D.L., Cutler G.B. Jr. Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann. Intern. Med. 96: 143, 1982.

    PubMed  CAS  Google Scholar 

  158. Franks S. Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.) 31: 87, 1989.

    CAS  Google Scholar 

  159. Tanabe K., Gagliano P., Channing C.P., Nakamura Y, Yoshimura Y, Lizuka R., Fortuny A., Sulewski J., Rezai N. Levels of inhibin-f activity and steroids in human follicular fluid from normal women and women with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 57: 24, 1983.

    PubMed  CAS  Google Scholar 

  160. Roy S., Mahesh V.B., Greenblatt R.B. Effect of dehydroepiandrosterone and Δ4 androstenedione on the reproductive organs of female rats: production of cyclic changes in the ovary. Nature 196: 42, 1962.

    PubMed  CAS  Google Scholar 

  161. Familiari G., Toscano V., Motta P. Morphological studies of polycystic mouse ovaries induced by dehydroepiandrosterone. Cell Tissue Res. 240: 519, 1985.

    PubMed  CAS  Google Scholar 

  162. Stewart P.M., Shackleton C.H.L., Beastall G.H., Edwards C.R.W. 5α-reductase activity in polycystic ovary syndrome Lancet 335: 431, 1990.

    PubMed  CAS  Google Scholar 

  163. Toscano V., Adamo M.V., Boscherini B., Pasquino A.M., Herlitzka L, Petrangeli E., Sciarra F. The hormone pattern in a case of arrhenoblastoma Eur. J. Pediatr. 136: 203, 1981.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di V Clinica Medica, Policlinico Umberto I, Università La Sapienza, 00161, Rome, Italy

    V. Toscano

Authors
  1. V. Toscano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toscano, V. Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors. J Endocrinol Invest 14, 153–170 (1991). https://doi.org/10.1007/BF03350293

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350293

Key-words

Search

Navigation